
Heal Capital
Description
Heal Capital is a prominent Berlin-based venture capital firm dedicated exclusively to the European HealthTech sector. With a robust fund of €100 million in assets under management, the firm positions itself as a key investor in the digital transformation of healthcare across the continent. Their investment thesis centers on supporting innovative companies that leverage technology to improve patient care, enhance operational efficiency, and redefine healthcare delivery models. Heal Capital primarily targets early-growth stage companies, participating in Seed, Series A, and Series B funding rounds, demonstrating a commitment to nurturing startups from their foundational phases through significant expansion.
The firm's investment strategy is characterized by a hands-on approach, extending beyond mere capital provision. Heal Capital aims to be a strategic partner, offering deep industry expertise, an extensive network, and operational guidance to its portfolio companies. This value-add is significantly bolstered by their unique backing from the German private health insurance association (PKV-Verband), providing unparalleled access to the German healthcare system and its stakeholders. This strategic alignment allows Heal Capital to facilitate market entry and scaling opportunities for its portfolio companies within one of Europe's largest healthcare markets.
Regarding their investment scope, Heal Capital typically deploys initial cheques ranging from €1 million to €10 million. This flexible ticket size enables them to accommodate a diverse range of funding needs, from early-stage ventures requiring foundational capital to more mature startups seeking significant growth equity. Their focus remains steadfast on companies that demonstrate strong potential for disruptive innovation and scalable business models within the HealthTech landscape, encompassing areas such as digital therapeutics, telemedicine, health data analytics, and AI-driven diagnostics. Heal Capital's commitment to the European HealthTech ecosystem underscores its role in fostering the next generation of healthcare innovators.
Investor Profile
Heal Capital has backed more than 30 startups, with 6 new investments in the last 12 months alone. The firm has led 14 rounds, about 47% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in Germany, United Kingdom, Poland.
- Strong thematic focus on Health Care, Artificial Intelligence (AI), Personal Health.
- Led 3 rounds in the past year.
- Typical check size: $1M – $10M.
Stage Focus
- Seed (47%)
- Series A (27%)
- Pre Seed (17%)
- Series B (10%)
Country Focus
- Germany (57%)
- United Kingdom (10%)
- Poland (7%)
- France (7%)
- Switzerland (7%)
- Canada (3%)
- The Netherlands (3%)
- Italy (3%)
- United States (3%)
Industry Focus
- Health Care
- Artificial Intelligence (Ai)
- Personal Health
- Medical
- Machine Learning
- Mhealth
- Software
- Analytics
- Health Diagnostics
- Biotechnology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.